The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders

被引：12

作者：

Alijanpour, Sahar ^{[1
]}

Miryounesi, Mohammad ^{[1
]}

Ghafouri-Fard, Soudeh ^{[1
]}

机构：

[1] Shahid Beheshti Univ Med Sci, Fac Med, Dept Med Genet, Tehran, Iran

来源：

METABOLIC BRAIN DISEASE | 2023年 / 38卷 / 01期

关键词：

SLC1A2; EAAT2; Developmental and epileptic encephalopathy 41; Epilepsy; Neurological disorders; Genetic; GLIAL GLUTAMATE TRANSPORTER; DE-NOVO MUTATIONS; AMYOTROPHIC-LATERAL-SCLEROSIS; FRAGILE-X-SYNDROME; ALZHEIMERS-DISEASE; MOLECULAR PHARMACOLOGY; HIPPOCAMPAL GLUTAMATE; ANTISENSE KNOCKDOWN; NEURONAL DAMAGE; MICE LACKING;

D O I：

10.1007/s11011-022-01091-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS). Excitatory amino acid transporters (EAATs) have important roles in the uptake of glutamate and termination of glutamatergic transmission. Up to now, five EAAT isoforms (EAAT1-5) have been identified in mammals. The main focus of this review is EAAT2. This protein has an important role in the pathoetiology of epilepsy. De novo dominant mutations, as well as inherited recessive mutation in this gene, have been associated with epilepsy. Moreover, dysregulation of this protein is implicated in a range of neurological diseases, namely amyotrophic lateral sclerosis, alzheimer's disease, parkinson's disease, schizophrenia, epilepsy, and autism. In this review, we summarize the role of EAAT2 in epilepsy and other neurological disorders, then provide an overview of the therapeutic modulation of this protein.

引用

页码：1 / 16

页数：16

共 152 条

[91] Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission [J].

Montanari, Martina ;

Martella, Giuseppina ;

Bonsi, Paola ;

Meringolo, Maria .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)

[92] GLT-1 Loss Accelerates Cognitive Deficit Onset in an Alzheimer's Disease Animal Model [J].

Mookherjee, Paramita ;

Green, Pattie S. ;

Watson, G. Stennis ;

Marques, Marcos A. ;

Tanaka, Kohichi ;

Meeker, Kole D. ;

Meabon, James S. ;

Li, Ning ;

Zhu, Ping ;

Olson, Valerie G. ;

Cook, David G. .

JOURNAL OF ALZHEIMERS DISEASE, 2011, 26 (03) :447-455

[93] De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies [J].

Myers, Candace T. ;

McMahon, Jacinta M. ;

Schneider, Amy L. ;

Petrovski, Slave ;

Allen, Andrew S. ;

Carvill, Gemma L. ;

Zemel, Matthew ;

Say-Kally, Julia E. ;

LaCroix, Amy J. ;

Heinzen, Erin L. ;

Hollingsworth, Georgina ;

Nikanorova, Marina ;

Corbett, Mark ;

Gecz, Jozef ;

Coman, David ;

Freeman, Jeremy ;

Calvert, Sophie ;

Gill, Deepak ;

Carney, Patrick ;

Lerman-Sagie, Tally ;

Sampaio, Hugo ;

Cossette, Patrick ;

Delanty, Norman ;

Dlugos, Dennis ;

Eichler, Evan E. ;

Epstein, Michael P. ;

Glauser, Tracy ;

Johnson, Michael R. ;

Kuzniecky, Ruben ;

Marson, Anthony G. ;

O'Brien, Terence J. ;

Petrou, Ruth Ottman Stephen ;

Poduri, Annapurna ;

Pickrell, William O. ;

Chung, Seo-Kyung ;

Rees, Mark I. ;

Sherr, Elliott ;

Sadleir, Lynette G. ;

Goldstein, David B. ;

Lowenstein, Daniel H. ;

Moller, Rikke S. ;

Berkovic, Samuel F. ;

Scheffer, Ingrid E. ;

Mefford, Heather C. .

AMERICAN JOURNAL OF HUMAN GENETICS, 2016, 99 (02) :287-298

[94] Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia [J].

O'Donovan, S. M. ;

Hasselfeld, K. ;

Bauer, D. ;

Simmons, M. ;

Roussos, P. ;

Haroutunian, V. ;

Meador-Woodruff, J. H. ;

McCullumsmith, R. E. .

TRANSLATIONAL PSYCHIATRY, 2015, 5 :e579-e579

[95] The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders [J].

O'Donovan, Sinead M. ;

Sullivan, Courtney R. ;

McCullumsmith, Robert E. .

NPJ SCHIZOPHRENIA, 2017, 3

[96] GLT1 gene delivery based on bone marrow-derived cells ameliorates motor function and survival in a mouse model of ALS [J].

Ohashi, Natsuko ;

Terashima, Tomoya ;

Katagi, Miwako ;

Nakae, Yuki ;

Okano, Junko ;

Suzuki, Yoshihisa ;

Kojima, Hideto .

SCIENTIFIC REPORTS, 2021, 11 (01)

[97]

OLNEY JW, 1995, ARCH GEN PSYCHIAT, V52, P998

[98] The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics [J].

Pajarillo, Edward ;

Rizor, Asha ;

Lee, Jayden ;

Aschner, Michael ;

Lee, Eunsook .

NEUROPHARMACOLOGY, 2019, 161

[99] Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders [J].

Parkin, Georgia M. ;

Udawela, Madhara ;

Gibbons, Andrew ;

Dean, Brian .

WORLD JOURNAL OF PSYCHIATRY, 2018, 8 (02) :51-63

[100]

Perkins Emma M, 2018, Hum Mol Genet, V27, P2614, DOI 10.1093/hmg/ddy169

← 5 6 7 8 9 10 11 12 13 14 →